Scotia Capital’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.16M | Sell |
2,968
-2,554
| -46% | -$1.08M | ﹤0.01% | 573 |
|
|
2026
Q1 | $2.61M | Sell |
5,522
-1,126
| -17% | -$567K | 0.01% | 404 |
|
|
2025
Q4 | $3.1M | Buy |
6,648
+235
| +4% | +$109K | 0.01% | 381 |
|
|
2025
Q3 | $2.73M | Buy |
6,413
+636
| +11% | +$247K | 0.01% | 400 |
|
|
2025
Q2 | $2.21M | Buy |
5,777
+139
| +2% | +$50.1K | 0.01% | 407 |
|
|
2025
Q1 | $1.95M | Sell |
5,638
-310
| -5% | -$99.7K | 0.01% | 404 |
|
|
2024
Q4 | $1.79M | Sell |
5,948
-946
| -14% | -$331K | 0.01% | 427 |
|
|
2024
Q3 | $2.8M | Buy |
6,894
+2,241
| +48% | +$820K | 0.02% | 347 |
|
|
2024
Q2 | $1.49M | Buy |
4,653
+655
| +16% | +$213K | 0.01% | 426 |
|
|
2024
Q1 | $1.33M | Buy |
+3,998
| New | +$1.22M | 0.01% | 444 |
|
|
2023
Q4 | – | Sell |
-5,209
| Closed | -$1.28M | – | 808 |
|
|
2023
Q3 | $1.28M | Sell |
5,209
-4,235
| -45% | -$1.16M | 0.01% | 414 |
|
|
2023
Q2 | $2.87M | Buy |
9,444
+6,807
| +258% | +$1.89M | 0.02% | 301 |
|
|
2023
Q1 | $695K | Buy |
2,637
+205
| +8% | +$52.1K | 0.01% | 495 |
|
|
2022
Q4 | $584K | Buy |
+2,432
| New | +$545K | ﹤0.01% | 535 |
|
|
2022
Q2 | – | Sell |
-11,363
| Closed | -$2.85M | – | 848 |
|
|
2022
Q1 | $2.85M | Buy |
11,363
+626
| +6% | +$157K | 0.02% | 346 |
|
|
2021
Q4 | $2.76M | Buy |
10,737
+305
| +3% | +$74.6K | 0.02% | 354 |
|
|
2021
Q3 | $2.53M | Buy |
+10,432
| New | +$2.55M | 0.02% | 357 |
|
|
2020
Q3 | – | Sell |
-40,244
| Closed | -$3.91M | – | 715 |
|
|
2020
Q2 | $3.91M | Buy |
40,244
+1,930
| +5% | +$201K | 0.05% | 179 |
|
|
2020
Q1 | $3.44M | Sell |
38,314
-1,732
| -4% | -$224K | 0.05% | 192 |
|
|
2019
Q4 | $5.92M | Sell |
40,046
-2,066
| -5% | -$277K | 0.07% | 160 |
|
|
2019
Q3 | $5.07M | Sell |
42,112
-2,182
| -5% | -$282K | 0.06% | 165 |
|
|
2019
Q2 | $5.99M | Buy |
44,294
+698
| +2% | +$88.3K | 0.07% | 147 |
|
|
2019
Q1 | $5.68M | Buy |
43,596
+2,629
| +6% | +$353K | 0.07% | 152 |
|
|
2018
Q4 | $5.1M | Buy |
40,967
+19,508
| +91% | +$2.62M | 0.08% | 150 |
|
|
2018
Q3 | $2.98M | Sell |
21,459
-7,603
| -26% | -$946K | 0.04% | 241 |
|
|
2018
Q2 | $2.79M | Sell |
29,062
-109
| -0.4% | -$11K | 0.04% | 237 |
|
|
2018
Q1 | $2.83M | Buy |
29,171
+6,137
| +27% | +$595K | 0.04% | 242 |
|
|
2017
Q4 | $2.02M | Buy |
+23,034
| New | +$1.85M | 0.03% | 293 |
|
Other funds holding HCA
Scotia Capital's HCA Position: Q2 2026 in Review
Scotia Capital reduced its HCA Healthcare (HCA) stake by 46% in Q2 2026, selling an estimated $1.08M and leaving 2,968 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #573.
Scotia Capital first reported a position in HCA in Q4 2017 and has held it in 28 quarters since. The position peaked at $5.99M in Q2 2019. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Scotia Capital held 2,968 shares of HCA Healthcare worth $1.16M as of Q2 2026.
- Scotia Capital sold 2,554 HCA Healthcare shares in Q2 2026, an estimated $1.08M.
- HCA Healthcare made up ﹤0.01% of Scotia Capital's portfolio in Q2 2026, its #573 holding.
- Scotia Capital first reported a position in HCA Healthcare in Q4 2017 and has held it in 28 quarters since.
- Scotia Capital's HCA Healthcare position peaked at $5.99M in Q2 2019.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.